Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial.
Tong Y, Zhang X, Chen J, Chen W, Wang Z, Li Q, Duan K, Wei S, Yang B, Qian X, Li J, Hang L, Deng S, Li X, Guo C, Shen H, Liu Y, Deng P, Xie T, Li Q, Li L, Du H, Mao Q, Gao F, Lu W, Guan X, Huang J, Li X, Chen X.
Tong Y, et al. Among authors: yang b.
EClinicalMedicine. 2022 Jul 29;52:101596. doi: 10.1016/j.eclinm.2022.101596. eCollection 2022 Oct.
EClinicalMedicine. 2022.
PMID: 35923425
Free PMC article.